menu
    • menu

    Company profile for Zevra Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners and advocacy groups in all of our clinical and regulatory development strategies.With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new ...
    We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners and advocacy groups in all of our clinical and regulatory development strategies.With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zevra TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1180 Celebration Boulevard, Suite 103 Celebration, FL 34747
    Telephone
    Telephone
    +1.888.958.1253
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://zevra.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zevra Therapeutics Announces Inducement Grants Under Nasdaq LR
    Zevra Therapeutics Announces Inducement Grants Under Nasdaq LR

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204880/16626/en/Zevra-Therapeutics-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Zevra Therapeutics Announces CFO Transition
    Zevra Therapeutics Announces CFO Transition

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3192387/16626/en/Zevra-Therapeutics-Inc-Announces-CFO-Transition.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Zevra Reports Q3 2025 Financial Results & Update
    Zevra Reports Q3 2025 Financial Results & Update

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181930/16626/en/Zevra-Reports-Third-Quarter-2025-Financial-Results-and-Corporate-Update.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Zevra Therapeutics Joins Guggenheim Healthcare Innovation Conf
    Zevra Therapeutics Joins Guggenheim Healthcare Innovation Conf

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176307/16626/en/Zevra-Therapeutics-to-Participate-in-the-Guggenheim-Healthcare-Innovation-Conference.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Zevra Therapeutics Reveals Q3 2025 Financial Results Call
    Zevra Therapeutics Reveals Q3 2025 Financial Results Call

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174460/16626/en/Zevra-Therapeutics-Announces-Details-for-Q3-2025-Financial-Results-Call.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Zevra Therapeutics Announces Inducement Grants Under Nasdaq LR
    Zevra Therapeutics Announces Inducement Grants Under Nasdaq LR

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3162167/16626/en/Zevra-Therapeutics-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search